Page 18 - Read Online
P. 18
Lust et al. Vessel Plus 2021;5:7 I http://dx.doi.org/10.20517/2574-1209.2020.52 Page 13 of 14
DECLARATIONS
Acknowledgments
The authors would like to acknowledge Ralph Mayer and Dr. Caroline Arnold for their technical assistance
in this study.
Authors’ contributions
Performed experiments, analyzed the data, and revised the manuscript: Lust L, Kuk H, Kohlhaas J
Performed the microarray analysis and the statistical evaluation: Sticht C
Designed the study, analyzed the data and wrote the manuscript: Korff T
Availability of data and materials
The raw and normalized data are deposited in the Gene Expression Omnibus database (http://www.ncbi.
nlm.nih.gov/geo/; accession No. GSE121557).
Financial support and sponsorship
This work was supported by the Swiss Society for Phlebology.
Conflicts of interest
All authors declare that there are no conflicts of interest.
Ethical approval and consent to participate
Human umbilical vein endothelial cells (HUVECs) were isolated as per approval from the Local Ethical
Committee (document number 336/2005, Heidelberg Germany) and conformed to the principles outlined
in the Declaration of Helsinki (1997). Parental consent was obtained for isolation of HUVECs from the
umbilical cords of newborns.
Consent for publication
Not applicable
Copyright
© The Author(s) 2021.
REFERENCES
1. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann
Epidemiol 2005;15:175-84.
2. Burkitt DP, Townsend AJ, Patel K, Skaug K. Varicose veins in developing countries. Lancet 1976;2:202-3.
3. Lee AJ, Evans CJ, Allan PL, Ruckley CV, Fowkes FG. Lifestyle factors and the risk of varicose veins: Edinburgh Vein Study. J Clin
Epidemiol 2003;56:171-9.
4. Durham JD, Machan L. Pelvic congestion syndrome. Semin Intervent Radiol 2013;30:372-80.
5. Feldner A, Otto H, Rewerk S, Hecker M, Korff T. Experimental hypertension triggers varicosis-like maladaptive venous remodeling
through activator protein-1. FASEB J 2011;25:3613-21.
6. Pfisterer L, König G, Hecker M, Korff T. Pathogenesis of varicose veins-lessons from biomechanics. Vasa 2014;43:88-99.
7. Ligi D, Croce L, Mannello F. Chronic venous disorders: the dangerous, the good, and the diverse. Int J Mol Sci 2018;19:2544.
8. Wali MA, Eid RA. Changes of elastic and collagen fibers in varicose veins. Int Angiol 2002;21:337-43.
9. Somers P, Knaapen M. The histopathology of varicose vein disease. Angiology 2006;57:546-55.
10. Sansilvestri-Morel P, Rupin A, Jaisson S, Fabiani JN, Verbeuren TJ, Vanhoutte PM. Synthesis of collagen is dysregulated in cultured
fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation 2002;106:479-83.
11. Lim CS, Davies AH. Pathogenesis of primary varicose veins. Br J Surg 2009;96:1231-42.
12. Gomez I, Benyahia C, Louedec L, et al. Decreased PGE 2 content reduces MMP-1 activity and consequently increases collagen density in
human varicose vein. PLoS One 2014;9:e88021.
13. Biagi G, Lapilli A, Zendron R, Piccinni L, Coccheri S. Prostanoid production in varicose veins: evidence for decreased prostacyclin with
increased thromboxane A2 and prostaglandin E2 formation. Angiology 1988;39:1036-42.

